Back

Effects of angiotensin-neprilysin inhibition as compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable de

18 March 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Ventricular tachycardia Ventricular Arrhythmias and SCD - Prevention EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Luis Gonzalez Torres

Hospital Vinalopo Health, Elche (Spain)

21 More presentations in this session

Presentation thumbnail
Doctor S. Themistoclakis (Venice, IT)
Abstract
Presentation thumbnail
Doctor D. Bera (Kolkata, IN)
Abstract Slides
Presentation thumbnail
Doctor M. Ibrahim (Leicester, GB)
Abstract
Presentation thumbnail
Mr D. Penela (Barcelona, ES)
Abstract
Presentation thumbnail
Ms A. Hendriks (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Ventricular tachycardia

The Event

Event poster

EHRA 2018

18 March 2018 08:30 CET
You may be interested in
thumbnail
ESC Journals
Impact of angiotensin-receptor neprilysin inhibitor on reverse cardiac remodeling in patients with heart failure with reduced ejection fraction (hfref)
4 February 2022
thumbnail
Congress Session
How to treat arrhythmias in heart failure
17 May 2025
thumbnail
Congress Presentation
Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs
29 August 2022
thumbnail
Congress Presentation
N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: data from the SMASH Study
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources